Decision will help accelerate vaccination on the European continent, which is facing the fourth wave of Covid-19 and has become the new global epicenter of the coronavirus pandemic
A European Medicines Agency (EMA) recommended this Thursday, 25, the application of the vaccine from Pfizer against a Covid-19 in children aged 5 to 11 years. The immunizing agent had its use in people over 12 years old approved by the EMA in May of this year. The decision by the agency’s Committee on Medicines for Human Use (CHMP) will help speed up vaccination on the European continent, which is facing the fourth wave of Covid-19 and became the new world epicenter of the pandemic of the coronavirus. The vaccine will be given in two doses of 10 µg — one-third the amount used in children over 12 years of age. The approved interval is three weeks between the first and second application.
Effectiveness of Pfizer in Children Between 5 and 11 Years
The study carried out by the pharmacist gathered about 2,000 children between 5 and 11 years old. According to researchers, dof the 1305 children who received the vaccine, three developed Covid-19 compared with 16 of the 663 children who received the placebo, an efficacy rate of 90.7% against the symptomatic form of the disease. The adverse effects observed in the tests were similar to those registered in other age groups. They include tiredness, headache, redness, pain and swelling at the injection site, muscle aches and chills. You USA already using Pfizer’s immunizing agent in this age group since the beginning of November.
Source From: Jovempan